Genome evolution of SARS-CoV-2 and its virological characteristics

被引:0
|
作者
So Nakagawa
Takayuki Miyazawa
机构
[1] Molecular Life Science,Micro/Nano Technology Center
[2] School of Medicine,Laboratory of Virus
[3] Institute of Medical Sciences,Host Coevolution
[4] Tokai University,Resilience Research Unit
[5] Tokai University,undefined
[6] Institute for Frontier Life and Medical Sciences,undefined
[7] Kyoto University,undefined
来源
Inflammation and Regeneration | / 40卷
关键词
COVID-19; Coronavirus; Comparative genomics; SARS-CoV-2; Viral evolution;
D O I
暂无
中图分类号
学科分类号
摘要
Coronavirus disease of 2019 (COVID-19), which originated in China in 2019, shows mild cold and pneumonia symptoms that can occasionally worsen and result in deaths. SARS-CoV-2 was reported to be the causative agent of the disease and was identified as being similar to SARS-CoV, a causative agent of SARS in 2003. In this review, we described the phylogeny of SARS-CoV-2, covering various related studies, in particular, focusing on viruses obtained from horseshoe bats and pangolins that belong to Sarbecovirus, a subgenus of Betacoronavirus. We also describe the virological characteristics of SARS-CoV-2 and compare them with other coronaviruses. More than 30,000 genome sequences of SARS-CoV-2 are available in the GISAID database as of May 28, 2020. Using the genome sequence data of closely related viruses, the genomic characteristics and evolution of SARS-CoV-2 were extensively studied. However, given the global prevalence of COVID-19 and the large number of associated deaths, further computational and experimental virological analyses are required to fully characterize SARS-CoV-2.
引用
收藏
相关论文
共 50 条
  • [1] Genome evolution of SARS-CoV-2 and its virological characteristics (vol 40, 17, 2020)
    Nakagawa, So
    Miyazawa, Takayuki
    INFLAMMATION AND REGENERATION, 2020, 40 (01)
  • [2] Virological characteristics and diagnosis of SARS-CoV-2
    Reina, Jordi
    Fraile, Pablo
    MEDICINA BALEAR, 2020, 35 (04): : 62 - 68
  • [3] Virological characteristics of the SARS-CoV-2 XEC variant
    Kaku, Yu
    Okumura, Kaho
    Kawakubo, Shusuke
    Uriu, Keiya
    Chen, Luo
    Kosugi, Yusuke
    Uwamino, Yoshifumi
    Begum, M. S. T. Monira
    Leong, Sharee
    Ikeda, Terumasa
    Sadamasu, Kenji
    Asakura, Hiroyuki
    Nagashima, Mami
    Yoshimura, Kazuhisa
    Ito, Jumpei
    See, Kei Sato
    LANCET INFECTIOUS DISEASES, 2024, 24 (12): : e736 - e736
  • [4] Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
    Giovanetti, Marta
    Benedetti, Francesca
    Campisi, Giovanni
    Ciccozzi, Alessandra
    Fabris, Silvia
    Ceccarelli, Giancarlo
    Tambone, Vittoradolfo
    Caruso, Arnaldo
    Angeletti, Silvia
    Zella, Davide
    Ciccozzi, Massimo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 88 - 91
  • [5] Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection
    Pinninti, Swetha G.
    Pati, Sunil
    Poole, Claudette
    Latting, Misty
    Seleme, Maria C.
    Yarbrough, April
    Arora, Nitin
    Britt, William J.
    Boppana, Suresh
    PEDIATRICS, 2021, 147 (05)
  • [6] Virological assessment of SARS-CoV-2
    Stower, Hannah
    NATURE MEDICINE, 2020, 26 (04) : 465 - 465
  • [7] Virological characteristics of the SARS-CoV-2 KP.2 variant
    Kaku, Yu
    Uriu, Keiya
    Kosugi, Yusuke
    Okumura, Kaho
    Yamasoba, Daichi
    Uwamino, Yoshifumi
    Kuramochi, Jin
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Asakura, Hiroyuki
    Nagashima, Mami
    Ito, Jumpei
    Sato, Kei
    LANCET INFECTIOUS DISEASES, 2024, 24 (07): : e416 - e416
  • [8] Virological assessment of SARS-CoV-2
    Hannah Stower
    Nature Medicine, 2020, 26 : 465 - 465
  • [9] Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48
    Wang, Wenqi
    Jin, Qiushi
    Liu, Ruixue
    Zeng, Wentao
    Zhu, Pengfei
    Li, Tingting
    Wang, Tiecheng
    Xiang, Haiyang
    Zhang, Hang
    Chen, Qin
    Gao, Yun
    Lai, Yana
    Yan, Fang
    Xia, Xianzhu
    Li, Jianmin
    Wang, Xuefeng
    Gao, Yuwei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Virological characteristics of the SARS-CoV-2 BA.2.86 variant
    Tamura, Tomokazu
    Mizuma, Keita
    Nasser, Hesham
    Deguchi, Sayaka
    Padilla-Blanco, Miguel
    Oda, Yoshitaka
    Uriu, Keiya
    Tolentino, Jarel E. M.
    Tsujino, Shuhei
    Suzuki, Rigel
    Kojima, Isshu
    Nao, Naganori
    Shimizu, Ryo
    Wang, Lei
    Tsuda, Masumi
    Jonathan, Michael
    Kosugi, Yusuke
    Guo, Ziyi
    Hinay, Alfredo A., Jr.
    Putri, Olivia
    Kim, Yoonjin
    Tanaka, Yuri L.
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Saito, Akatsuki
    Ito, Jumpei
    Irie, Takashi
    Tanaka, Shinya
    Zahradnik, Jiri
    Ikeda, Terumasa
    Takayama, Kazuo
    Matsuno, Keita
    Fukuhara, Takasuke
    Sato, Kei
    CELL HOST & MICROBE, 2024, 32 (02) : 170 - 180.e12